TherapeuticsMD
TXMD
$1.97
Share price
-1.00%
Change (1 day)
-48.83%
Change (1 year)
Categories
Market capitalization of TherapeuticsMD (TXMD)
Market cap: $22.71 Million
As of June 2024 TherapeuticsMD has a market cap of $22.71 Million. This makes TherapeuticsMD the world's 8084th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of TherapeuticsMD from 2003 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $22.71 M | -4.51% |
| 2023 | $23.79 M | -55.04% |
| 2022 | $52.92 M | -64.97% |
| 2021 | $0.15 B | -58.35% |
| 2020 | $0.36 B | -44.73% |
| 2019 | $0.65 B | -28.37% |
| 2018 | $0.91 B | -29.92% |
| 2017 | $1.30 B | 15.25% |
| 2016 | $1.13 B | -38.53% |
| 2015 | $1.84 B | 165.62% |
| 2014 | $0.69 B | -8.04% |
| 2013 | $0.75 B | 144.18% |
| 2012 | $0.30 B | 153.95% |
| 2011 | $0.12 B | 23605.68% |
| 2010 | $0.51 M | -97.5% |
| 2009 | $20.52 M | 1244.2% |
| 2008 | $1.52 M | 192.57% |
| 2007 | $0.52 M | -52.65% |
| 2006 | $1.1 M | 33.33% |
| 2005 | $0.82 M | 46.43% |
| 2004 | $0.56 M | -9.45% |
| 2003 | $0.62 M |
End of Day market cap according to different sources
On Jun 17th, 2024 the market cap of TherapeuticsMD was reported to be:
$22.94 Million
$22.94 Million
$22.94 Million
$22.94 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $154.38 B | 679,417.49% | 🇺🇸 USA |
 AbbVie ABBV | $303.03 B | 1,333,669.13% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.17 M | -90.43% | 🇺🇸 USA |
 Royalty Pharma RPRX | $15.75 B | 69,241.67% | 🇬🇧 UK |
 Lannett Company LCI | $7.38 M | -67.52% | 🇺🇸 USA |